Primary and secondary end points were demonstrated in a phase 3 trial of subcutaneous marstacimab as treatment for patients ...

On-body delivery systems for subcutaneous isatuximab could enable patient self-administration, according to Xavier Leleu, MD, PhD, improving convenience and transforming treatment for ...

Purpose: To compare the anesthetic effectiveness of topical proparacaine drops, subconjunctival lidocaine, and 2% lidocaine gel. Methods: Ninety-two patients undergoing intravitreal injections were ...

The Trump administration has moved to end funding for a broad swath of HIV vaccine research, saying current approaches are enough to counter the virus, multiple scientists and federal health ...

Subconjunctival hemorrhage is a common ophthalmic disease. It usually does not cause serious visual impairment, but it may be an early sign of serious diseases such as leukemia, hemophilia and ...

A growing number of physicians are starting to shift their thinking about multiple myeloma’s prognosis. For years, patients have been told that multiple myeloma is treatable but not curable. Yet data ...

This fact has been emphasized by many authors. 1–6 Malamud et al. 2 analyzed the autopsy material of 125 cases of heatstroke and found multiple hemorrhages in 122, particularly in the central ...

Patti Scialfa, Bruce Springsteen’s wife and bandmate, said she has multiple myeloma. Here's what to know about the blood cancer's signs, symptoms and treatment.

Subconjunctival hemorrhage (SCH) is a common cause of a bleeding eye. It occurs due to a burst blood vessel and typically affects the whites of the eyes. Another cause of an eye bleed is a hyphema.

Subconjunctival hemorrhage is a condition that happens when blood vessels break beneath the eye's surface, causing a visible red spot. Learn more at WebMD.